Molina Healthcare Inc (MOH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $10.89B
Last updated: Nov 17, 2026 at 11:06 AM ET
Molina Healthcare Inc (MOH) Earnings: Report Dates and Results
Molina Healthcare (MOH) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Molina Healthcare reported EPS of $0.89, above the $0.72 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
MOH has an expected report date of Feb 3, 2027.
MOH Earnings Call
The latest MOH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, MOH beat 30, missed 7 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $11.08B, down 3.5% from $11.48B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.89 | $0.72 | $0.69 - $1.68 | +23.61% | Beat | -51.6% | 18 | 0 up, 2 down | Oct 21, 2026 | $11.08B |
| Jun 30, 2026 | $1.51 | $1.37 | $0.98 - $2.04 | +10.22% | Beat | -72.4% | 17 | 0 up, 3 down | Jul 22, 2026 | $10.87B |
| Mar 31, 2026 | $2.35 | $1.91 | $1.02 - $3.14 | +23.04% | Beat | -61.3% | 16 | 0 up, 4 down | Apr 22, 2026 | $10.80B |
| Dec 31, 2025 | -$2.75 | $0.50 | -$0.33 - $0.86 | -649.78% | Miss | -154.5% | 17 | 0 up, 2 down | Feb 5, 2026 | $11.38B |
| Sep 30, 2025 | $1.84 | $3.89 | $2.89 - $4.35 | -52.70% | Miss | -69.4% | 17 | 0 up, 1 down | Oct 22, 2025 | $11.48B |
| Jun 30, 2025 | $5.48 | $5.53 | $5.11 - $6.11 | -0.90% | Miss | -6.5% | 13 | 0 up, 10 down | Jul 23, 2025 | $11.43B |
| Mar 31, 2025 | $6.08 | $5.96 | $4.82 - $6.16 | +2.01% | Beat | +6.1% | 14 | 0 up, 2 down | Apr 23, 2025 | $11.15B |
| Dec 31, 2024 | $5.05 | $5.88 | $5.43 - $6.15 | -14.12% | Miss | +15.3% | 13 | 1 up, 0 down | Feb 5, 2025 | $10.50B |
| Sep 30, 2024 | $6.01 | $5.94 | $5.70 - $6.18 | +1.18% | Beat | +19.0% | 14 | 0 up, 1 down | Oct 23, 2024 | $10.34B |
| Jun 30, 2024 | $5.86 | $5.60 | $4.70 - $6.03 | +4.64% | Beat | +3.7% | 14 | 0 up, 1 down | Jul 24, 2024 | $9.88B |
| Mar 31, 2024 | $5.73 | $5.64 | $5.21 - $6.36 | +1.60% | Beat | -1.4% | 15 | 1 up, 2 down | Apr 24, 2024 | $9.93B |
| Dec 31, 2023 | $4.38 | $4.35 | $4.24 - $4.50 | +0.69% | Beat | +6.8% | 12 | 0 up, 0 down | Feb 7, 2024 | $9.05B |
| Sep 30, 2023 | $5.05 | $4.87 | $4.67 - $5.06 | +3.70% | Beat | +15.8% | 14 | 0 up, 0 down | Oct 25, 2023 | $8.55B |
| Jun 30, 2023 | $5.65 | $5.13 | $4.55 - $5.71 | +10.14% | Beat | +24.2% | 16 | 4 up, 0 down | Jul 26, 2023 | $8.33B |
| Mar 31, 2023 | $5.81 | $5.21 | $4.75 - $5.63 | +11.52% | Beat | +18.6% | 16 | 1 up, 0 down | Apr 26, 2023 | $8.15B |
| Dec 31, 2022 | $4.10 | $4.02 | $3.93 - $4.34 | +1.99% | Beat | +42.4% | 16 | 2 up, 0 down | Feb 8, 2023 | $8.22B |
| Sep 30, 2022 | $4.36 | $4.23 | $4.00 - $4.34 | +3.07% | Beat | +54.1% | 14 | 2 up, 0 down | Oct 26, 2022 | $7.93B |
| Jun 30, 2022 | $4.55 | $4.37 | $3.85 - $4.60 | +4.12% | Beat | +33.8% | 14 | 1 up, 1 down | Jul 27, 2022 | $8.05B |
| Mar 31, 2022 | $4.90 | $4.68 | $4.45 - $5.17 | +4.70% | Beat | +10.4% | 14 | 2 up, 0 down | Apr 27, 2022 | $7.77B |
| Dec 31, 2021 | $2.88 | $2.76 | $2.63 - $3.20 | +4.35% | Beat | -12.5% | 16 | 0 up, 0 down | Feb 9, 2022 | $7.41B |
| Sep 30, 2021 | $2.83 | $2.80 | $2.70 - $2.99 | +1.07% | Beat | -15.8% | 13 | N/A | Oct 27, 2021 | $7.04B |
| Jun 30, 2021 | $3.40 | $3.40 | $3.09 - $3.95 | 0.00% | In line | -29.0% | 13 | N/A | Jul 28, 2021 | $6.80B |
| Mar 31, 2021 | $4.44 | $3.71 | $3.15 - $4.41 | +19.68% | Beat | +47.0% | 12 | N/A | Apr 28, 2021 | $6.52B |
| Dec 31, 2020 | $3.29 | $0.82 | $0.46 - $1.58 | +301.22% | Beat | +20.5% | 11 | N/A | Feb 10, 2021 | $5.24B |
| Sep 30, 2020 | $3.36 | $2.18 | $1.79 - $2.45 | +54.13% | Beat | +20.0% | 10 | N/A | Oct 28, 2020 | $5.02B |
| Jun 30, 2020 | $4.79 | $4.95 | $2.95 - $6.21 | -3.23% | Miss | +54.0% | 11 | N/A | Jul 30, 2020 | $4.62B |
| Mar 31, 2020 | $3.02 | $3.00 | $2.70 - $3.27 | +0.67% | Beat | -0.7% | 12 | N/A | Apr 30, 2020 | $4.55B |
| Dec 31, 2019 | $2.73 | $2.65 | $2.55 - $2.76 | +3.02% | Beat | -11.1% | 15 | N/A | Feb 10, 2020 | $4.27B |
| Sep 30, 2019 | $2.80 | $2.73 | $2.64 - $2.84 | +2.56% | Beat | -5.7% | 16 | N/A | Oct 29, 2019 | $4.24B |
| Jun 30, 2019 | $3.11 | $2.70 | $2.10 - $3.60 | +15.19% | Beat | +1.0% | 15 | N/A | Jul 30, 2019 | $4.19B |
| Mar 31, 2019 | $3.04 | $2.45 | $2.05 - $2.80 | +24.08% | Beat | +128.6% | 15 | N/A | Apr 29, 2019 | $4.12B |
| Dec 31, 2018 | $3.07 | $1.54 | $1.39 - $1.99 | +99.35% | Beat | N/A | 12 | N/A | Feb 11, 2019 | $4.66B |
| Sep 30, 2018 | $2.97 | $1.65 | $1.41 - $1.86 | +80.00% | Beat | N/A | 14 | N/A | Oct 31, 2018 | $4.70B |
| Jun 30, 2018 | $3.08 | $1.09 | $0.85 - $1.41 | +182.57% | Beat | N/A | 15 | N/A | Jul 31, 2018 | $4.88B |
| Mar 31, 2018 | $1.33 | $0.77 | $0.34 - $1.22 | +72.73% | Beat | -9.5% | 12 | N/A | Apr 30, 2018 | $4.65B |
| Dec 31, 2017 | -$4.52 | $0.17 | -$0.63 - $0.94 | N/A | N/A | N/A | 14 | N/A | Feb 12, 2018 | $4.95B |
| Sep 30, 2017 | -$1.62 | $0.14 | -$0.74 - $0.88 | N/A | N/A | -290.6% | 10 | N/A | Nov 2, 2017 | $5.03B |
| Jun 30, 2017 | -$4.01 | $0.87 | $0.70 - $1.08 | -560.92% | Miss | -698.5% | 14 | N/A | Aug 2, 2017 | $5.00B |
| Mar 31, 2017 | $1.47 | $0.58 | N/A | +153.45% | Beat | +188.2% | N/A | N/A | May 2, 2017 | $4.90B |
| Dec 31, 2016 | -$1.54 | $0.75 | N/A | -305.33% | Miss | -320.0% | N/A | N/A | Feb 15, 2017 | $4.53B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $10.65, down 53.0% from the year before. It was $0.49 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $10.65 | -53.0% |
| Dec 31, 2024 | $22.65 | +8.4% |
| Dec 31, 2023 | $20.89 | +16.6% |
| Dec 31, 2022 | $17.91 | +32.2% |
| Dec 31, 2021 | $13.55 | -6.3% |
| Dec 31, 2020 | $14.46 | +23.8% |
| Dec 31, 2019 | $11.68 | +11.8% |
| Dec 31, 2018 | $10.45 | N/A |
| Dec 31, 2017 | -$8.68 | -1871.4% |
| Dec 31, 2016 | $0.49 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,000 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,035 | 17 | |
| 2026Q2 | Jun 30, 2026 | 8,094 | 17 | |
| 2026Q1 | Mar 31, 2026 | 8,429 | 19 | |
| 2025Q4 | Dec 31, 2025 | 9,173 | 16 | |
| 2025Q3 | Sep 30, 2025 | 8,970 | 17 | |
| 2025Q2 | Jun 30, 2025 | 10,103 | 16 | |
| 2025Q1 | Mar 31, 2025 | 7,740 | 17 | |
| 2024Q4 | Dec 31, 2024 | 9,219 | 13 |
2026Q3 Earnings Call
Opening remarks
Jeff Geyer Investor Relations The conference is now being recorded. The conference has not been initiated. You will be placed on hold until a chairperson arrives. Good morning, and welcome to Molina Healthcare's third quarter 2026 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky, and our CFO, Mark Keim. A press release announcing our third quarter 2026 earnings was distributed after the market closed yesterday and is available on our investor relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listen to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, October 22nd, 2026, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2026 guidance and expected segment performance, rates and medical cost trend, the implementation and performance of the Florida CMS contract, our preliminary 2027 premium and earnings outlook and related building blocks, Marketplace pricing, footprint, and program integrity initiatives, Medicare Stars and duals performance, Medicaid work requirements and reverifications and associated medical costs, our RFP awards and implementation timing, our long-term financial targets, and the amount and realization of embedded earnings. Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC, as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions. I will now turn the call over to our Chief Executive Officer, Joe Zubretsky. Joe?
Joe Zubretsky CEO Thank you, Jeff, and good morning. Today, I will discuss several topics: our third quarter results, our reaffirmed full year 2026 guidance, and our preliminary 2027 premium and earnings outlook. Let me start with our third quarter performance. Last night, we reported adjusted earnings per share of $0.89 on $10.5 billion of premium revenue. Our 92.9% consolidated MCR reflects solid operating performance as we continue to navigate a challenging medical cost environment. We produced a 0.6% adjusted pre-tax margin in the quarter and 1.1% year to date.
Frequently Asked Questions About MOH
When is Molina Healthcare's next earnings date?
Molina Healthcare's next earnings report is expected for Feb 3, 2027.
Did MOH beat earnings estimates last quarter?
Yes. Molina Healthcare reported EPS of $0.89 for the quarter ended Sep 30, 2026, above the $0.72 estimate, a 23.61% surprise.
What EPS do analysts expect from MOH next quarter?
The consensus EPS estimate for Molina Healthcare for the quarter ending Dec 31, 2026 is $0.54 from 21 analysts, with estimates from $0.44 to $0.77.
How often does MOH beat earnings estimates?
Molina Healthcare beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -82.33%.
MOH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors